<SEC-DOCUMENT>9999999995-23-001063-index.html : 20230428
<SEC-HEADER>9999999995-23-001063.hdr.sgml : 20230428
<ACCEPTANCE-DATETIME>20230428001516
ACCESSION NUMBER:		9999999995-23-001063
CONFORMED SUBMISSION TYPE:	EFFECT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230427
DATE AS OF CHANGE:		20230428
EFFECTIVENESS DATE:		20230427

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Avalo Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001534120
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				450705648
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		EFFECT
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-254000
		FILM NUMBER:		23859791

	BUSINESS ADDRESS:	
		STREET 1:		540 GAITHER ROAD
		STREET 2:		SUITE 400
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		410-522-8707

	MAIL ADDRESS:	
		STREET 1:		540 GAITHER ROAD
		STREET 2:		SUITE 400
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cerecor Inc.
		DATE OF NAME CHANGE:	20111102
</SEC-HEADER>
<DOCUMENT>
<TYPE>EFFECT
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>